Jubilant Pharmova's shares close 7.14% lower day after Q4 loss

Jubilant Pharmova's shares closed 7.14% lower on BSE after its Q4 loss widened to ₹97.84 crore. The company also informed that USFDA classified their Montreal CMO Facility as "Official Action Indicated", which will lead to withholding approval of any pending applications or supplements in which this facility is listed. Hari S Bhartia also stepped down from the MD's post.